Assertio Hldgs Earnings Estimates, EPS & Revenue | NASDAQ:ASRT

Comments

Assertio Holdings Inc Earnings Estimates

ASRTNASDAQ

Trade with Public

$18.02

N/A

At close: Apr 10, 5:00 PM EST

$18.02

N/A

After Hours: 7:20 PM EST

M&A: Assertio Hldgs (ASRT) announced it will be acquired by Cosette Pharmaceuticals, Inc on Wednesday, April 8, 2026

Overview NewsEarningsGuidance Analyst Ratings Insider Trades Short Interest Stock Report

Assertio Hldgs Earnings Estimates, EPS & Revenue | NASDAQ:ASRT

Assertio Hldgs (ASRT) is scheduled to report Q1 earnings on May 11, 2026. Analysts estimate EPS of $-1.31 and quarterly revenue of $10.93M.

In the most recent quarter (Q4), Assertio Hldgs reported EPS of $-1.06, beating estimates of $-2.30 by 0.54%. Revenue came in at $13.54M, exceeding the estimate of $5.62M by 1.41%.

Assertio Hldgs has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, Assertio Hldgs has averaged an EPS surprise of 2.34% and a revenue surprise of 0.59%.

Earnings Date

May 11

EPS Estimate

$-1.310

Quarterly Revenue Estimate

$10.93M

Annual Revenue
(as of Dec 31)

$118.71M

Assertio Hldgs Earnings History

Analyze the earnings history of Assertio Hldgs using advanced sorting and filters.

Loading calendar...

Assertio Hldgs (ASRT) Earnings Per Share

The chart below shows Assertio Hldgs's reported EPS compared to analyst estimates over recent quarters.

Assertio Hldgs (ASRT) Revenue

The chart below shows Assertio Hldgs's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Assertio Hldgs (NASDAQ:ASRT) reporting earnings?

Assertio Hldgs (ASRT) is scheduled to report earnings on May 11, 2026. The last reported earnings were for reported on March 16, 2026 for Q4.

What were the latest earnings per share (EPS) for Assertio Hldgs (NASDAQ:ASRT)?

The Actual EPS was $-1.06, which beat the estimate of $-2.30.

What were Assertio Hldgs’s (NASDAQ:ASRT) revenues?

The Actual Revenue was $13.54M, which beat the estimate of $5.62M.

People Also Watch

Aardvark Therapeutics Inc

NASDAQ:AARD

$3.97

0.76%

Rani Therapeutics Holdings Inc

Impact BioMedical Inc

Sol-Gel Technologies Ltd

NASDAQ:SLGL

$74.86

Assertio Hldgs Earnings Estimates, EPS & Revenue | NASDAQ:ASRT

Assertio Hldgs (ASRT) is scheduled to report Q1 earnings on May 11, 2026. Analysts estimate EPS of $-1.31 and quarterly revenue of $10.93M.

In the most recent quarter (Q4), Assertio Hldgs reported EPS of $-1.06, beating estimates of $-2.30 by 0.54%. Revenue came in at $13.54M, exceeding the estimate of $5.62M by 1.41%.

Assertio Hldgs has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, Assertio Hldgs has averaged an EPS surprise of 2.34% and a revenue surprise of 0.59%.

Earnings Date

May 11

EPS Estimate

$-1.310

Quarterly Revenue Estimate

$10.93M

Annual Revenue
(as of Dec 31)

$118.71M